Biotech Investment Research Intern

Biotech Equity Research Analyst Intern

Daimyo Holdings is seeking a Biotech Equity Research Intern to join our Investment Team based in West Los Angeles, California. This internship centers on researching and analyzing publicly traded Biotechnology and Pharmaceutical companies with an emphasis on identifying strong Growth Prospects, robust Pharmaceutical Pipelines, and companies whose research and potential are undervalued.

This role is well suited for candidates pursuing an advanced degree in a life science field (e.g., Biology, Biochemistry, Pharmacology, or a related discipline) who want to apply their scientific training to investment research. Prior exposure to equity research, private equity, venture capital, or investment analysis is a plus but not required.

Interns will support the buildout of in-depth models and presentations that explain early- to late-stage biotechnology and pharmaceutical products, their makeup, potential, competitive advantage, and intrinsic value. Being able to articulate why a company is investable or not is crucial, and all research must be supported by clear and concise evidence.

The role requires strong research skills, problem solving, and thorough critical thinking. Collaboration is desired and encouraged; you will interface regularly with external scientists, data specialists, and other medical professionals whose opinions, analysis, and research may be of use. Candidates must be intellectually curious and able to listen and communicate effectively with our senior investment staff.

• Support in-depth market research and analysis to help identify potentially impactful investment opportunities in the Biotechnology and Pharmaceutical sectors, particularly in Therapeutics.
• Help monitor and analyze industry trends, competitive landscape, and regulatory changes to inform investment strategy.
• Assist in building and maintaining financial models, dashboards, and reports.
• Collaborate with other team members to support the execution of investment strategies.
• Help synthesize data analysis and market research into actionable insights for senior management.
• Assist in developing research-based investment theses and assembling detailed presentations to support investment decisions.
• Stay up-to-date with the latest advancements in healthcare therapeutics and emerging technologies.
• Support the Investment Director in building out a long-term Biotechnology, Pharmaceutical, and Healthcare portfolio of publicly traded companies.
• Opportunity to attend industry-related events and conferences, domestic and (occasionally) global.

• Currently pursuing an advanced degree (Master's or PhD) in Biology, Chemistry, Biochemistry, or a related life science field. Open to candidates pursing a degree in Finance or a related field who have a strong interest in the biotechnology and healthcare sector.
• Prior experience or coursework in a research, analyst, or similar capacity, preferably related to investment management or healthcare, is a plus but not required.
• Strong analytical skills; familiarity with Excel required, and exposure to SQL and/or Bloomberg Terminal is a plus.
• Strong communication and presentation skills, with the ability to convey complex scientific information to a non-scientific audience.
• Strong problem-solving skills and attention to detail.

This is an unpaid internship. Schedule and duration to be discussed with candidates based on availability and academic commitments. Interns are required to be in the office on a scheduled frequency; adherence to this schedule is essential to fulfilling the expectations of the role.

Daimyo Holdings believes all individuals are entitled to equal employment opportunity and advancement opportunities without regard to race, religious creed, color, sex, national origin, ancestry, physical disability, mental disability, medical condition, genetic information, marital status, gender, gender identity, gender expression, age for individuals forty years of age and older, military and veteran status, sexual orientation, and any other basis protected by applicable federal, state, and local laws.

Daimyo Holdings does not discriminate or adopt any policy that discriminates against an individual or any group of individuals on any of these bases.